ALPHAEON Strengthens Global Leadership With New Senior Appointments

Jan 28, 2016, 06:00 ET from ALPHAEON Corporation

IRVINE, Calif., Jan. 28, 2016 /PRNewswire/ -- ALPHAEON Corporation, a social commerce company and subsidiary to Strathspey Crown Holdings LLC, today announced it has strengthened its global leadership with the appointment of Clint Carnell as President of Europe, Middle East and Africa and David Barrios as Vice President of Canada and Latin America.

Mr. Carnell and Mr. Barrios both bring successful track records building a broad spectrum of companies to their new positions. Mr. Carnell will be responsible for strengthening ALPHAEON's leadership presence in EMEA, fostering product innovation and growth across those markets, while Mr. Barrios will oversee strategy, growth and management of the Canadian and Latin American markets.

"We are thrilled to welcome Clint and David to ALPHAEON's growing team of accomplished executives," said ALPHAEON President and Chief Operating Officer Bob Rhatigan. "Clint's deep expertise in specialty healthcare's self-pay sector bolsters our EMEA leadership and our global presence, while David's extensive experience in ophthalmology and medical aesthetics extends ALPHAEON's commitment to deliver innovative products, services and solutions to physicians and consumers globally. Both additions advance our strategy to provide our customers with local service presence internationally while leveraging ALPHAEON's proprietary ShoutMD social commerce platform globally."

Prior to joining ALPHAEON, Mr. Carnell was President and Chief Executive Officer of Perseon Corporation, a life sciences company dedicated to the research, development and production of energy ablation devices used to treat soft tissue tumors. Previously, Mr. Carnell was CEO of Myoscience, Inc. and prior to this served as COO of Solta Medical Inc., which was later sold to Valeant Pharmaceuticals. Early in Mr. Carnell's career, he served as VP of US Surgical Business for Bausch + Lomb.

"ALPHAEON is striving to create a new vision for the self-pay healthcare industry," said Mr. Carnell. "I believe my experience in the ophthalmic and aesthetic medical device market will fit well with the company as it continues to expand globally."

With nearly 15 years developing solutions for medical businesses, Mr. Barrios has helped implement strategic initiatives across a roster of leading healthcare companies. Prior to joining ALPHAEON, Mr. Barrios was a General Manager of Galderma's Spain & Portugal region where he led their three global business units located in Iberia. Previously, Mr. Barrios held the position of Business Unit Director Surgical, Spain & Portugal, for Bausch + Lomb, where he led strategic plan definition and implementation. In addition, he held senior leadership positions within Johnson & Johnson and American Express.

"It's an honor to join a company with a strong network of board-certified physicians and a strong innovative vision," said David Barrios, ALPHAEON VP Canada and Latin America. "I'm looking forward to leveraging my experience to grow ALPHAEON's presence and reputation in support of medical solutions in the Canadian and Latin American regions."

About ALPHAEON Corporation
ALPHAEON Corporation is a social commerce company with the goal of transforming self-pay healthcare by bringing to market highly innovative products and services to promote consumer wellness, beauty and performance. The company works in partnership with board certified physicians ensuring access to leading advancements in lifestyle healthcare. For more information, please visit

About Strathspey Crown Holdings, LLC 
Strathspey Crown is a growth equity firm specializing in lifestyle healthcare. The firm is founded in partnership with physician investors across key medical specialties including plastic surgery, ophthalmology, dermatology, dentistry and orthopedics. For more information, please visit

Jenna Mons, Senior Vice President of Marketing and Communications
Tel: +1-904-343-3449